VERICEL CORPORATION Depreciation
VERICEL CORPORATION (VCEL) reported Depreciation of $3.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-30
- VERICEL CORPORATION depreciation for the quarter ending 2026-06-30 was $3.50M, a 29.63% increase year-over-year.
- VERICEL CORPORATION depreciation for the quarter ending 2026-03-31 was $3.10M, a 24.00% increase year-over-year.
- VERICEL CORPORATION depreciation for the quarter ending 2025-12-31 was $2.90M, a 107.14% increase year-over-year.
- VERICEL CORPORATION depreciation for the quarter ending 2025-09-30 was $2.80M, a 133.33% increase year-over-year.
- VERICEL CORPORATION depreciation for fiscal 2025 was $10.90M, a 122.45% increase from fiscal 2024.
- VERICEL CORPORATION depreciation for fiscal 2024 was $4.90M, a 22.50% increase from fiscal 2023.
- VERICEL CORPORATION depreciation for fiscal 2023 was $4.00M, a 0.00% change from fiscal 2022.
- VERICEL CORPORATION depreciation for fiscal 2022 was $4.00M, a 33.33% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $3.50M 10-Q · filed 2026-07-30 | $6.60M 10-Q · filed 2026-07-30 | $9.50M derived: sum of 3 quarters · filed 2026-07-30 | $12.30M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $3.10M 10-Q · filed 2026-05-07 | $6.00M derived: sum of 2 quarters · filed 2026-05-07 | $8.80M derived: sum of 3 quarters · filed 2026-05-07 | $11.50M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.70M derived: sum of 2 quarters · filed 2026-02-26 | $8.40M derived: sum of 3 quarters · filed 2026-07-30 | $10.90M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $2.80M 10-Q · filed 2025-11-06 | $5.50M derived: sum of 2 quarters · filed 2026-07-30 | $8.00M 10-Q · filed 2025-11-06 | $9.40M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $2.70M 10-Q · filed 2026-07-30 | $5.20M 10-Q · filed 2026-07-30 | $6.60M derived: sum of 3 quarters · filed 2026-07-30 | $7.80M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $2.50M 10-Q · filed 2026-05-07 | $3.90M derived: sum of 2 quarters · filed 2026-05-07 | $5.10M derived: sum of 3 quarters · filed 2026-05-07 | $6.30M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.60M derived: sum of 2 quarters · filed 2026-02-26 | $3.80M derived: sum of 3 quarters · filed 2026-02-26 | $4.90M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.20M 10-Q · filed 2025-11-06 | $2.40M derived: sum of 2 quarters · filed 2025-11-06 | $3.50M 10-Q · filed 2025-11-06 | $4.60M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $1.20M 10-Q · filed 2025-07-31 | $2.40M 10-Q · filed 2025-07-31 | $3.40M derived: sum of 3 quarters · filed 2026-02-26 | $4.40M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $1.20M 10-Q · filed 2025-05-08 | $2.20M derived: sum of 2 quarters · filed 2026-02-26 | $3.20M derived: sum of 3 quarters · filed 2026-02-26 | $4.20M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.00M derived: sum of 2 quarters · filed 2026-02-26 | $3.00M derived: sum of 3 quarters · filed 2026-02-26 | $4.00M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $1.00M 10-Q · filed 2024-11-07 | $2.00M derived: sum of 2 quarters · filed 2024-11-07 | $3.00M 10-Q · filed 2024-11-07 | $4.10M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $1.00M 10-Q · filed 2024-08-01 | $2.00M 10-Q · filed 2024-08-01 | $3.10M derived: sum of 3 quarters · filed 2025-02-27 | $4.10M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $1.00M 10-Q · filed 2024-05-08 | $2.10M derived: sum of 2 quarters · filed 2025-02-27 | $3.10M derived: sum of 3 quarters · filed 2025-02-27 | $4.20M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.10M derived: sum of 2 quarters · filed 2025-02-27 | $3.20M derived: sum of 3 quarters · filed 2025-02-27 | $4.00M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $1.00M 10-Q · filed 2023-11-08 | $2.10M derived: sum of 2 quarters · filed 2023-11-08 | $2.90M 10-Q · filed 2023-11-08 | $3.80M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $1.10M 10-Q · filed 2023-08-02 | $1.90M 10-Q · filed 2023-08-02 | $2.80M derived: sum of 3 quarters · filed 2024-02-29 | $3.50M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $900.00K 10-Q · filed 2023-05-10 | $1.70M derived: sum of 2 quarters · filed 2024-02-29 | $2.40M derived: sum of 3 quarters · filed 2024-02-29 | $3.10M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.50M derived: sum of 2 quarters · filed 2024-02-29 | $2.20M derived: sum of 3 quarters · filed 2024-02-29 | $3.00M 10-K · filed 2024-02-29 | $2.96M 10-K · filed 2022-02-24 |
| 2021-09-30 | $700.00K 10-Q · filed 2021-11-09 | $1.40M derived: sum of 2 quarters · filed 2021-11-09 | $2.20M 10-Q · filed 2021-11-09 | $2.98M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2021-06-30 | $700.00K 10-Q · filed 2021-08-04 | $1.50M 10-Q · filed 2021-08-04 | $2.28M derived: sum of 3 quarters · filed 2022-02-24 | $2.88M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2021-03-31 | $800.00K 10-Q · filed 2021-05-05 | $1.58M derived: sum of 2 quarters · filed 2022-02-24 | $2.18M derived: sum of 3 quarters · filed 2022-02-24 | $2.68M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-12-31 | $783.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.38M derived: sum of 2 quarters · filed 2022-02-24 | $1.88M derived: sum of 3 quarters · filed 2022-02-24 | $2.38M 10-K · filed 2022-02-24 | $2.40M 10-K · filed 2021-02-24 |
| 2020-09-30 | $600.00K 10-Q · filed 2021-11-09 | $1.10M derived: sum of 2 quarters · filed 2021-11-09 | $1.60M 10-Q · filed 2021-11-09 | $2.14M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $500.00K 10-Q · filed 2021-08-04 | $1.10M 10-Q · filed 2021-08-04 | $1.54M derived: sum of 3 quarters · filed 2022-02-24 | $1.94M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $500.00K 10-Q · filed 2021-05-05 | $1.04M derived: sum of 2 quarters · filed 2022-02-24 | $1.44M derived: sum of 3 quarters · filed 2022-02-24 | $1.84M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $544.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $944.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.34M derived: sum of 3 quarters · filed 2022-02-24 | $1.74M 10-K · filed 2022-02-24 | $1.70M 10-K · filed 2020-02-25 |
| 2019-09-30 | $400.00K 10-Q · filed 2020-11-05 | $800.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.20M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $400.00K 10-Q · filed 2020-08-05 | $700.00K 10-Q · filed 2020-08-05 | |||
| 2019-03-31 | $300.00K 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | $1.40M 10-K · filed 2021-02-24 | ||||
| 2017-12-31 | $1.60M 10-K · filed 2020-02-25 | ||||
| 2016-12-31 | $1.60M 10-K · filed 2019-02-26 | ||||
| 2015-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $700.00K derived: sum of 2 quarters · filed 2018-03-05 | $900.00K derived: sum of 3 quarters · filed 2018-03-05 | $1.30M 10-K · filed 2018-03-05 | |
| 2015-09-30 | $400.00K 10-Q · filed 2015-11-13 | $600.00K derived: sum of 2 quarters · filed 2015-11-13 | $1.00M 10-Q · filed 2015-11-13 | ||
| 2015-06-30 | $200.00K 10-Q · filed 2015-08-12 | $500.00K 10-Q · filed 2015-08-12 | |||
| 2014-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $600.00K derived: sum of 2 quarters · filed 2017-03-13 | $700.00K derived: sum of 3 quarters · filed 2017-03-13 | $800.00K 10-K · filed 2017-03-13 | |
| 2014-09-30 | $200.00K 10-Q · filed 2015-11-13 | $300.00K derived: sum of 2 quarters · filed 2015-11-13 | $400.00K 10-Q · filed 2015-11-13 | ||
| 2014-06-30 | $100.00K 10-Q · filed 2015-08-12 | $200.00K 10-Q · filed 2015-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |